sb 202190 has been researched along with Kidney Neoplasms in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Kidney Neoplasms: Tumors or cancers of the KIDNEY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ch'ng, WC | 1 |
| Abd-Aziz, N | 1 |
| Ong, MH | 1 |
| Stanbridge, EJ | 1 |
| Shafee, N | 1 |
1 other study available for sb 202190 and Kidney Neoplasms
| Article | Year |
|---|---|
Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway.
Topics: Active Transport, Cell Nucleus; Apoptosis; Blotting, Western; Carcinoma, Renal Cell; Cell Line, Tumo | 2015 |